DMXAA (Vadimezan) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase.

Verteporfin is a small molecule that inhibits TEAD–YAP association and YAP-induced liver overgrowth.

Plinabulin is an orally active diketopiperazine derivative with potential antineoplastic activity.

Degrasyn is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor.

Bafetinib is a potent and selective dual Bcr-Abl/Lyn inhibitor.

TAE684 is a potent and selective ALK inhibitor.

Fostamatinib disodium, a prodrug of the active metabolite R406, is a Syk inhibitor.

R406 (free base) is a potent Syk inhibitor.